Safety of Gadolinium-Based Contrast Agents in Patients With Stage 4 and 5 Chronic Kidney Disease: A Radiologist’s Perspective

Kidney360
doi 10.34067/kid.0000502019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy